Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

This publication has 25 references indexed in Scilit:

• Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
  JAMA, 2002
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering
  The American Journal of Cardiology, 2000
• Cancer incidence in a kidney-transplanted population
  Transplant International, 2000
• CHOLESTEROL AS AN INDEPENDENT PREDICTOR OF OUTCOME AFTER RENAL TRANSPLANTATION
  Transplantation, 2000
• Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience. REVIEW ARTICLE
  Journal of Clinical Pharmacy & Therapeutics, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• IMPACT OF SERUM LIPIDS ON LONG-TERM GRAFT AND PATIENT SURVIVAL AFTER RENAL TRANSPLANTATION1
  Transplantation, 1995
• Hyperlipidaemia in renal transplantation—risk factor for long‐term graft outcome
  European Journal of Clinical Investigation, 1995